ClinicalTrials.Veeva

Menu

Oxygenation Test During General Anesthesia

R

Region Västmanland

Status

Completed

Conditions

Morbid Obesity

Treatments

Procedure: CPAP and 31% oxygen
Procedure: No CPAP and 100% oxygen
Procedure: CPAP and 100% oxygen

Study type

Interventional

Funder types

Other

Identifiers

NCT01559402
Dnr 2011 / 462

Details and patient eligibility

About

The study investigates if applying a special ventilatory strategy during anesthesia for laparoscopic gastric by pass, produces less atelectasis and better oxygenation in spite of using 100 % oxygen during pre oxygenation and induction of anesthesia. The study investigates oxygenation with blood gas samples but also with a new method that might give more information without the use of blood gas samples.

Primary: Oxygenation in patients with morbid obesity improves if preoxygenation, induction and maintenance of anesthesia is performed with either a continuous positive airway pressure (CPAP) or a positive end expiratory pressure (PEEP), respectively, of 10 cm H2O, in comparison to a technique without CPAP but with a PEEP of 10 cm H2O.

Secondary: The improved oxygenation during anesthesia can be prolonged inte the postoperative period if emergence from anesthesia is performed without high levels of oxygen.

Enrollment

40 patients

Sex

All

Ages

18 to 50 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Adult patients scheduled for elective surgery of Morbid Obesity.
  • ASA 1-2. (ASA = American Society of Anesthesiologists classification).
  • "Body mass index" (BMI) ≥ 35 but < 50

Exclusion criteria

  • "ASA 3"
  • Anticipated difficult intubation.
  • Major bleeding.
  • Problems with ventilation necessitating protocol aberrations.
  • Obstructive sleep apnea syndrome with CPAP treatment at home.
  • Angina Pectoris

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Factorial Assignment

Masking

Single Blind

40 participants in 3 patient groups

Start O2 100% and CPAP 10, end O2 100%.
Experimental group
Description:
This arm describes some aspects of ventilation during anesthesia for laparoscopic gastric bypass. Pre-oxygenation is with an inspiratory oxygen fraction(FIO2) of 1.0, supplied by a continuous positive airway pressure of 10 centimeters of water(cmH2O), during anesthesia a positive end-expiratory pressure of 10 cmH2O is used and during emergence from anesthesia a FIO2 of 1.0 is used. The intervention associated with this arm is labeled CPAP and 100% oxygen.
Treatment:
Procedure: CPAP and 100% oxygen
Start O2 100% and CPAP 10, end O2 31%.
Experimental group
Description:
This arm describes some aspects of ventilation during anesthesia for laparoscopic gastric bypass. Pre-oxygenation is with a FIO2 of 1.0, supplied by a continuous positive airway pressure of 10 cmH2O, during anesthesia a positive end-expiratory pressure of 10 cmH2O is used and during emergence from anesthesia a FIO2 of 0.3 is used. The intervention associated with this arm is labeled CPAP and 31% oxygen.
Treatment:
Procedure: CPAP and 31% oxygen
Start O2 100% and CPAP 0, end O2 100%.
Experimental group
Description:
This arm describes some aspects of ventilation during anesthesia for laparoscopic gastric bypass. Pre-oxygenation is with a FIO2 of 1.0, without a continuous positive airway pressure, during anesthesia a positive end-expiratory pressure of 10 cmH2O is used and during emergence from anesthesia a FIO2 of 1.0 is used. The intervention associated with this arm is labeled No CPAP and 100% oxygen.
Treatment:
Procedure: No CPAP and 100% oxygen

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems